Clinton, Tennessee Seabrook, Texas (1) 4. Shanghai, China (4) Canada Quebec, Canada Shanghai, China (3) 10. Committees: 1, 3 RICHARD A.

Manufacturers have the ability to design and validate to meet UL criteria, including: • UL 94 V-0 • UL 94 V-1 • UL 94 V-2 NON-HALOGENATED CHOICES Silcosperse flame retardants are also available as non-halogenated formulations. X X X TiO2 Improves char. X X X Filler Reduces cost X X X Platinum Flame retardant X X X Extra All peroxides including DBPH catalyst X X X Heat Stabilizer Allows for higher heat in longer periods X X Carbon Black Smoke suppressant X Flame retardant grades may be blended to achieve desired results.

History Originally called HT-1, Nomex® was first developed in the 1960’s and made commercially available in 1967. NOMEX® META-ARAMID DATA META-ARAMID (HM) BARE FIBER PERFORMANCE * Equilibrium moisture regain @ 55% RH ** Creep @ 40%-58% ultimate tensile strength *** Shrinkage in dry air @ 177 C for 30 minutes MOVING HIGH PERFORMANCE FIBERS FORWARD ABOUT FIBER-LINE® LOCATIONS Headquarters, R&D, Manufacturing FIBER-LINE® LLC 3050 Campus Drive Hatfield, PA 19440 +1 215.997.9181 fiber@fiber-line.com Manufacturing Operations FIBER-LINE® LLC 280 Performance Drive SE Hickory, NC 28602 +1 828.326.8700 fiber@fiber-line.com EMEA & Asia Pacific Operations FIBER-LINE® INTERNATIONAL B.V. Uranusweg 3 8938 AJ Leeuwarden The Netherlands +31(0) 58 216 75 99 info@fiber-line.com NOTICE: The information and data contained herein do not constitute sales specifications.

PMMA Considering lens performance, Resilience™ LS Frost PVC offers properties and material performance similar to PMMA, often at a significantly lower cost. 1 ASTM D-1003 measured by Polymer Diagnostics, Inc. PDI) on extruded profiles 2 ASTM D-638 3 ASTM 256 4 ASTM D-648 66 psi, unannealed, 0.125" 5 Savings depends on profile size and production volume Acrylite is a registered trademark of Evonik Performance Materials Lens Performance Resilience™ LS Frost PVC Acrylite® Satinice Frost PMMA Light Transmission1 at 0.060" (1.5mm) 83% Low Diffusion 78% Medium Diffusion 75% High Diffusion 81% Low Diffusion Diffusion Half Power Angle (DLD) 26° Low Diffusion 41° Medium Diffusion 58° High Diffusion 26° Low Diffusion Tensile Strength2 Tensile Modulus2 Tensile Elongation (break)2 7,360 psi 400,000 psi 20% 7,330 psi 330,000 psi 43% Flammability (UL 94) V-0 @ 1.5mm 5VA @ 2.0mm HB @ 1.6mm Notched Izod Impact (73°F)3 2.3 ft-lb/in 0.6 ft-lb/in Heat Deflection Temperature4 157°F/69°C 182°F/83°C UV Stability Good Excellent Chemical Resistance Excellent Good Typical Lens Profile Cost 10–15% Savings5 Baseline 1.866.POLYONE www.polyone.com Copyright © 2018, PolyOne Corporation.

Medical Hoses - Case Study Versalloy formulation boosts productivity for medical hose manufacturer

Globale Richtlinie von Avient zur Bekämpfung von Bestechung und Korruption (Anti-Bribery and Anti-Corruption, ABAC) Veröffentlicht: 1. Juli 2020 Inhaltsangabe Unsere globale Richtlinie zur Bekämpfung von Bestechung und Korruption 1 Bedeutung der Compliance 1 Unsere Verantwortung 1 Was ist Bestechung? 2 Bestechung von Staatsbediensteten 2 Bestechung im Wirtschaftsleben 3 Gefälligkeitszahlungen und Schmiergelder 3 Zusammenarbeit mit Vertretern, Vertriebspartnern und anderen Drittparteien 3 Due Diligence und Genehmigungsverfahren 4 Warnsignale 4 Anforderungen an die Buchführung 4 Meldung möglicher Verstöße 5 Ethik-Hotline von Avient 5 Schutz vor Vergeltungsmaßnahmen 5 Kurzübersicht: Richtige und falsche Handlungsweisen im Zusammenhang mit ABAC 6 1 Unsere globale Richtlinie zur Bekämpfung von Bestechung und Korruption Avient untersagt ausdrücklich Betrug, Bestechung und andere korrupte Geschäftspraktiken bei all seinen Geschäftstätigkeiten weltweit.

August 4, 2014

X ET-8303-1C X ET-8303-1B SPOUT CAP Q728-3-2 GREY 3 TPE

Use of Non GAAP Measures Page 3 -150.00% -100.00% -50.00% 0.00% 50.00% 100.00% 150.00% 200.00% 250.00% 300.00% 350.00% PolyOne S&P 500 Strategy and Execution Drive Results – Since 2006: Page 4 All time closing high of $26.63 May 28, 2013 • 14 consecutive quarters of double digit EPS growth • 380 basis point increase in return on sales • 300% share price expansion • 300% increase in total shareholder return • 42% CAGR EPS expansion • $1.8 billion increase in market cap • Track record of successful acquisitions The World’s Premier Provider of Specialized Polymer Materials, Services & Solutions Four Pillar Strategy Page 5 2013 Portfolio Transformation Highlights • Substantial organic mix improvement drives 29% increase in first quarter EPS – 14th consecutive quarter of double-digit EPS growth • Completed acquisition of Spartech • Announced the creation of a new Specialty segment – Designed Structures and Solutions • Completed the sale of our non-core resin assets • Realigned our Specialty Coatings business into our GCAI segment Page 6 PP&S 15% Specialty 60% Distribution 25% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010* 2011* 2012* 2015 Target A dj us te d Ea rn in gs P er S ha re Appliance 6% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 4% Consumer 9% Packaging 18% Industrial 10% Misc. 5% HealthCare 9% Transportation 16% Textiles 1% United States 70% Europe 14% Canada 8% Asia 5% Latin America 3% 2012 Revenues: $4.0 Billion* End Markets* 2012 Revenues: $4.0 Billion* EPS Page 7 * Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms & excludes discontinued operations PolyOne At A Glance * Restated to exclude discontinued operations Old PolyOne Transformation *Operating Income excludes corporate charges and special items **Pro Forma results include Spartech and Glasforms acquisitions, Specialty Coatings reclass and excludes resin assets 2% 34% 43% 45% 60% 65 – 75% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2012 2012PF** 2015 % o f O pe ra ti ng In co m e* JV's PP&S Distribution Specialty Specialty OI $5M $46M $87M $114M $150M Target Mix Shift Highlights Specialty Transformation 2015 Target Page 8 2007 Q1 2013 2015 Target 1) Operating Income % Specialty: Global Color, Additives & Inks 4.6% 11.7% 12 – 16% Global Specialty Engineered Materials 1.3% 10.1% 12 – 16% Designed Structures & Solutions -- 4.6% 8 – 10% Performance Products & Solutions 6.1% 8.1% 9 – 12% Distribution 3.0% 6.0% 6 – 7.5% 2) Specialty Platform % of Operating Income 20% 60% 65 – 75% 3) ROIC* (after-tax) 7% 9.2% 15% 4) Adjusted EPS Growth N/A 29% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 9 *Percentage of Specialty Platform revenue from products introduced in last five years 19.5% 50.0% 2006 Q1 2013 $20.3 $41.9 2006 2012 14.3% 27.8% 2006 Q1 2013 Research & Development Spending Specialty Platform Vitality Index Progression* Innovation Drives Earnings Growth ($ millions) Specialty Platform Gross Margin % Page 10 We are Experts in Polymer Science and Formulation  Polymer Science  Formulation  Chemistry  Processing Inputs  Base Resins  Additives  Modifiers  Colorants Specialized Polymer Materials, Services, and Solutions Expertise Satisfied Consumers PolyOne Customer Innovative Products & Services  Marketplace Demands  Performance Requirements  Value Drivers Page 11 Positioned for Strong Growth 2015 Target Rev: $5B Adj. EPS: $2.50 Assumptions • Operating margins in mid-range of 2015 targets • No global recession • No investment in incremental PP&S capacity • Completion of 2-3 midsize accretive acquisitions • Housing starts at 85% of 50 year norm by 2015 • Mid single digit revenue CAGR • Remain comfortably below 3X Net Debt / EBITDA Page 12 2012 Rev: $2.9B Adj. EPS: $1.00 First Quarter Financial Highlights • 14th consecutive quarter of double digit adjusted earnings per share growth • 29 percent increase in adjusted EPS  34 percent increase in Specialty operating income  Growth from all regions  Virtually all organic growth • Strengthened our financial position Page 13 • Total Debt at 3/31/13 Less: Cash Net Debt • Available Liquidity Cash ABL Availability Total Liquidity • Net Debt / EBITDA = 2.7x* $169 285 $454 $1,056 169 $887 $50 $360 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2013 ($ millions) Page 14 Coupon Rates: 7.500% 7.375% 5.250% *Pro Forma TTM with no synergies related to Spartech acquisition & excludes resin assets Debt Maturities & Liquidity Summary – 3/31/13 Cash Balance = $169M Net Debt / EBITDA* = 2.7x • Repurchased 840k shares in Q1 2013 • 19.1 million shares are available for repurchase under the current authorization Share Repurchase • Introduced a quarterly dividend in Q1 2011 and increased in Q1 2012 (25%) and Q1 2013 (20%) • Objective of maintaining and growing Dividends • Expanding our sales, marketing, and technical capabilities is top priority • Investing in operational and LSS initiatives (including synergy capture) • CAPEX Organic Growth • Targets that expand our: • Specialty offering • End market presence • Geographic footprint • Synergy opportunities • Adjacent material solutions Acquisitions *TTM with no synergies related to the Spartech acquisition Use of Cash Page 15 Why Invest In PolyOne?

Use of Non GAAP Measures Page 3 -150.00% -100.00% -50.00% 0.00% 50.00% 100.00% 150.00% 200.00% 250.00% 300.00% 350.00% PolyOne S&P 500 Strategy and Execution Drive Results Page 4 • Since 2006, PolyOne stock has expanded approximately 300% vs. a 30% increase in the S&P 500 All time closing high of $26.63 May 28, 2013 The World’s Premier Provider of Specialized Polymer Materials, Services & Solutions Four Pillar Strategy Page 5 2013 Portfolio Transformation Highlights • Substantial organic mix improvement drives 29% increase in first quarter EPS – 14th consecutive quarter of double-digit EPS growth • Completed acquisition of Spartech • Announced the creation of a new Specialty segment – Designed Structures and Solutions • Completed the sale of our non-core resin assets • Realigned our Specialty Coatings business into our GCAI segment Page 6 0.12 0.27 0.21 0.13 0.68 0.82 1.00 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010* 2011* 2012* 2015 Target A dj us te d Ea rn in gs P er S ha re Appliance 6% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 4% Consumer 9% Packaging 18% Industrial 10% Misc. 5% HealthCare 9% Transportation 16% Textiles 1% PP&S 15% Specialty 60% Distribution 25% United States 70% Europe 14% Canada 8% Asia 5% Latin America 3% 2012 Revenues: $4.0 Billion* End Markets* 2012 Revenues: $4.0 Billion* EPS Page 7 * Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms & excludes resin assets PolyOne At A Glance * Restated to exclude discontinued operations Old PolyOne Transformation *Operating Income excludes corporate charges and special items **Pro Forma results include Spartech and Glasforms acquisitions, Specialty Coatings reclass and excludes resin assets 2% 34% 43% 45% 60% 65 – 75% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2012 2012PF** 2015 % o f O pe ra ti ng In co m e* JV's PP&S Distribution Specialty Specialty OI $5M $46M $87M $114M $150M Target Mix Shift Highlights Specialty Transformation 2015 Target Page 8 2007 Q1 2013 2015 Target 1) Operating Income % Specialty: Global Color, Additives & Inks 4.6% 11.7% 12 – 16% Global Specialty Engineered Materials 1.3% 10.1% 12 – 16% Designed Structures & Solutions -- 4.6% 8 – 10% Performance Products & Solutions 6.1% 8.1% 9 – 12% Distribution 3.0% 6.0% 6 – 7.5% 2) Specialty Platform % of Operating Income 20% 60% 65 – 75% 3) ROIC* (after-tax) 7% 9.2% 15% 4) Adjusted EPS Growth N/A 29% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 9 *Percentage of Specialty Platform revenue from products introduced in last five years 19.5% 50.0% 2006 Q1 2013 $20.3 $41.9 2006 2012 14.3% 27.8% 2006 Q1 2013 Research & Development Spending Specialty Platform Vitality Index Progression* Innovation Drives Earnings Growth ($ millions) Specialty Platform Gross Margin % Page 10 Positioned for Strong Growth 2015 Target Rev: $5B Adj. EPS: $2.50 Assumptions • Operating margins in mid-range of 2015 targets • No global recession • No investment in incremental PP&S capacity • Completion of 2-3 midsize accretive acquisitions • Housing starts at 85% of 50 year norm by 2015 • Mid single digit revenue CAGR • Remain comfortably below 3X Net Debt / EBITDA Page 11 2012 Rev: $2.9B Adj. EPS: $1.00 First Quarter Financial Highlights • 14th consecutive quarter of double digit adjusted earnings per share growth • 29 percent increase in adjusted EPS  34 percent increase in Specialty operating income  Growth from all regions  Virtually all organic growth • Strengthened our financial position Page 12 • Total Debt at 3/31/13 Less: Cash Net Debt • Available Liquidity Cash ABL Availability Total Liquidity • Net Debt / EBITDA = 2.7x* $169 285 $454 $1,056 169 $887 $50 $360 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2013 ($ millions) Page 13 Coupon Rates: 7.500% 7.375% 5.250% *Pro Forma TTM with no synergies related to Spartech acquisition & excludes resin assets Debt Maturities & Liquidity Summary – 3/31/13 Cash Balance = $169M Net Debt / EBITDA* = 2.7x • Repurchased 840k shares in Q1 2013 • 19.1 million shares are available for repurchase under the current authorization Share Repurchase • Introduced a quarterly dividend in Q1 2011 and increased in Q1 2012 (25%) and Q1 2013 (20%) • Objective of maintaining and growing Dividends • Expanding our sales, marketing, and technical capabilities is top priority • Investing in operational and LSS initiatives (including synergy capture) • CAPEX Organic Growth • Targets that expand our: • Specialty offering • End market presence • Geographic footprint • Synergy opportunities • Adjacent material solutions Acquisitions *TTM with no synergies related to the Spartech acquisition Use of Cash Page 14 Why Invest In PolyOne?